Rectocele
Showing 201 - 225 of 246
Atrial Fibrillation, Stroke Trial in Worldwide (dabigatran etexilate)
Terminated
- Atrial Fibrillation
- Stroke
- dabigatran etexilate
-
La Mesa, California
- +49 more
May 8, 2014
Pain Trial in Worldwide (OROS hydromorphone HCl, Oxycodone)
Breast Tumors Trial in Worldwide (Tamoxifen, Exemestane)
Completed
- Breast Neoplasms
-
Birmingham, Alabama
- +379 more
Apr 21, 2014
Excessive Daytime Sleepiness, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome Trial in Worldwide (Armodafinil 100 to 250
Completed
- Excessive Daytime Sleepiness
- +3 more
- Armodafinil 100 to 250 mg/day
-
Birmingham, Alabama
- +99 more
Jul 12, 2013
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium 18 mcg, tiotropium 1.25 mcg (2 actuations/day), tiotropium
Completed
- Pulmonary Disease, Chronic Obstructive
- tiotropium 18 mcg
- +2 more
-
Athens, Alabama
- +1190 more
May 20, 2014
Elevated High-sensitivity C-Reactive Protein (hsCRP) Trial in Worldwide (Rosuvastatin, Placebo)
Terminated
- Elevated High-sensitivity C-Reactive Protein (hsCRP)
- Rosuvastatin
- Placebo
-
Birmingham, Alabama
- +858 more
Feb 6, 2014
Endometrial Hyperplasia, Osteoporosis Trial in United States (Bazedoxifene/Conjugated Estrogen, CE 0.45 mg/MPA 1.5mg, Placebo)
Completed
- Endometrial Hyperplasia
- Osteoporosis
- Bazedoxifene/Conjugated Estrogen
- +2 more
-
Upland, California
- +8 more
Oct 30, 2013
Effect of Somatropin on Growth Hormone Deficient Adults
Completed
- Hypopituitarism
- +2 more
- Somatropin (rDNA origin)
- (no location specified)
Mar 25, 2014
Type 2 Diabetes Trial in Worldwide (Alogliptin, Metformin, Glipizide)
Alzheimer's Disease Trial in Puerto Rico, United States (Rivastigmine 4.6 mg/24 h (5 cm^2), Rivastigmine 9.5 mg/24 h (10 cm^2),
Completed
- Alzheimer's Disease
- Rivastigmine 4.6 mg/24 h (5 cm^2)
- +3 more
-
Tempe, Arizona
- +94 more
Aug 19, 2013
Cardiovascular Diseases Trial in Worldwide (Telmisartan, Combination of Telmisartan and Ramipril, Ramipril)
Rheumatoid Arthritis Trial in Worldwide (tocilizumab [RoActemra/Actemra], Placebo, Methotrexate)
Completed
- Rheumatoid Arthritis
- tocilizumab [RoActemra/Actemra]
- +2 more
-
Birmingham, Alabama
- +151 more
Dec 18, 2013
Lupus Erythematosus, Systemic Trial in Canada, United States (Placebo, Belimumab 1 mg/kg, Belimumab 4 mg/kg)
Completed
- Lupus Erythematosus, Systemic
- Placebo
- +3 more
-
Birmingham, Alabama
- +61 more
Aug 1, 2013
Macular Edema Secondary to Central Retinal Vein Occlusion Trial in Worldwide (VEGF Trap-Eye 2.0mg, Sham)
Completed
- Macular Edema Secondary to Central Retinal Vein Occlusion
- VEGF Trap-Eye 2.0mg
- Sham
-
Phoenix, Arizona
- +60 more
Apr 16, 2013
Postmenopausal Osteoporosis Trial in Worldwide (risedronate)
Completed
- Postmenopausal Osteoporosis
-
Lakewood, Colorado
- +48 more
Apr 15, 2013
Essential Hypertension Trial in Worldwide (Azilsartan medoxomil and chlorthalidone, Olmesartan medoxomil and
Completed
- Essential Hypertension
- Azilsartan medoxomil and chlorthalidone
- Olmesartan medoxomil and hydrochlorothiazide
-
Graz, Styria, Austria
- +25 more
Oct 15, 2012
Osteoporosis Trial in Worldwide (SMC021 Oral calcitonin, SMC021 Placebo)
Completed
- Osteoporosis
- SMC021 Oral calcitonin
- SMC021 Placebo
-
Gainesville, Georgia
- +15 more
Oct 22, 2012
Macular Degeneration Trial in Canada, United States (ranibizumab, aflibercept injection (VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Degeneration
- ranibizumab
- aflibercept injection (VEGF Trap-Eye, BAY86-5321)
-
Birmingham, Alabama
- +187 more
Dec 20, 2012
Multiple Sclerosis Trial in Worldwide (Fingolimod, Placebo)
Allergic Rhinitis, Perennial Allergic Rhinitis Trial in United States (Ciclesonide HFA 80 mcg, Ciclesonide HFA 160 mcg, Placebo)
Completed
- Allergic Rhinitis
- Perennial Allergic Rhinitis
- Ciclesonide HFA 80 mcg
- +2 more
-
Huntington Beach, California
- +44 more
Jun 7, 2012
Multiple Sclerosis Trial in Canada, United States (Fampridine-SR b.i.d. (Twice Daily))
Completed
- Multiple Sclerosis
- Fampridine-SR b.i.d. (Twice Daily)
-
Phoenix, Arizona
- +21 more
Mar 1, 2012
Bone Loss, Breast Cancer Trial in Worldwide (Zoledronic acid, Letrozole)
Completed
- Bone Loss
- Breast Cancer
- Zoledronic acid
- Letrozole
-
Buenos Aires, Argentina
- +105 more
Apr 10, 2012